Veeva Systems (VEEV)

• Market cap: $36.7B
• 1 day: -1.29%
• 5 days: -2.79%
• 1 month: 1.23%
• 3 months: 5.24%
• 6 months: 12.09%
• Year to date: 7.22%
• 1 year: 4.35%
• 5 years: 41.28%
• 10 years: 652.88%
• Sector: Information Technology
• Industry: Prepackaged Software

About: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Employees: 7,172

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

53% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 79

24% more call options, than puts

Call options by funds: $356M | Put options by funds: $288M

8% more repeat investments, than reductions

Existing positions increased: 347 | Existing positions reduced: 320

2% more capital invested

Capital invested by funds: $26.9B [Q3] → $27.4B (+$462M) [Q4]

0.77% more ownership

Funds ownership: 79.26% [Q3] → 80.03% (+0.77%) [Q4]

0% more funds holding

Funds holding: 937 [Q3] → 939 (+2) [Q4]

19% less funds holding in top 10

Funds holding in top 10: 16 [Q3] → 13 (-3) [Q4]

Research analyst outlook

18 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $195 14% downside
• Avg. target: $259 15% upside
• High target: $307 36% upside

18 analyst ratings

• positive: 10 56%
• neutral: 6 33%
• negative: 2 11%

Goldman Sachs Gabriela Borges 76% 1-year accuracy 22 / 29 met price target	11% downside $200	Sell Downgraded	23 Jan 2025
Needham Ryan MacDonald 56% 1-year accuracy 38 / 68 met price target	20% upside $270	Buy Reiterated	17 Jan 2025
Truist Securities Jailendra Singh 42% 1-year accuracy 16 / 38 met price target	7% downside $210	Hold Maintained	13 Jan 2025
Keybanc Scott Schoenhaus 67% 1-year accuracy 24 / 36 met price target	13% upside $255	Overweight Maintained	8 Jan 2025
Morgan Stanley Craig Hettenbach 33% 1-year accuracy 2 / 6 met price target	14% downside $195	Underweight Maintained	17 Dec 2024